Literature DB >> 7845223

Purification and kinetic characterization of human cytomegalovirus assemblin.

M C Smith1, J Giordano, J A Cook, M Wakulchik, E C Villarreal, G W Becker, K Bemis, J Labus, J S Manetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7845223     DOI： 10.1016/0076-6879(94)44031-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

2.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad.

Authors:  G A Cox; M Wakulchik; L M Sassmannshausen; W Gibson; E C Villarreal
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase.

Authors:  A R Welch; E C Villarreal; W Gibson
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Dimerization-Induced Allosteric Changes of the Oxyanion-Hole Loop Activate the Pseudorabies Virus Assemblin pUL26N, a Herpesvirus Serine Protease.

Authors:  Martin Zühlsdorf; Sebastiaan Werten; Barbara G Klupp; Gottfried J Palm; Thomas C Mettenleiter; Winfried Hinrichs
Journal:  PLoS Pathog       Date:  2015-07-10       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.